Intra-tibial injection of human prostate cancer cell line CWR22 elicits osteoblastic response in immunodeficient rats.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of musculoskeletal & neuronal interactions

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 15758355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker

  2004cited by this paper
• Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

  2002cited by this paper
• Osteoprotegerin and rank ligand expression in prostate cancer.

  2001cited by this paper
• Pathophysiologic interactions in skeletal metastasis

  2000cited by this paper
• Bisphosphonates in the management of prostate carcinoma metastatic to the skeleton

  2000cited by this paper
• Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases

  2000cited by this paper
• Establishment of human prostate carcinoma skeletal metastasis models

  2000cited by this paper
• Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.

  1999cited by this paper
• Skeletal metastasis of prostate adenocarcinoma in rats: Morphometric analysis and role of parathyroid hormone‐related protein

  1999cited by this paper
• Molecular cytogenetic studies of a serially transplanted primary prostatic carcinoma xenograft (CWR22) and four relapsed tumors

  1999cited by this paper
• The pharmacology of bisphosphonates and new insights into their mechanisms of action

  1999cited by this paper
• Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone.

  1998cited by this paper
• Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.

  1998cited by this paper
• Hypercalcemia of malignancy.

  1997cited by this paper
• Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices.

  1997cited by this paper
• Parathyroid hormone‐related protein and hypercalcemia

  1997cited by this paper
• A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.

  1997cited by this paper
• CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.

  1996cited by this paper
• Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.

  1996cited by this paper
• Metastatic prostate cancer in a transgenic mouse.

  1996cited by this paper
• Critical factors in the biology of human cancer metastasis.

  1995cited by this paper
• The geography of prostate cancer and its treatment in Europe.

  1995cited by this paper
• Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.

  1994cited by this paper
• Xenografts of primary human prostatic carcinoma.

  1993cited by this paper
• Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data.

  1993cited by this paper
• Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer

  1993cited by this paper
• Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases.

  1993cited by this paper
• Animal models for the study of prostate carcinogenesis

  1992cited by this paper
• Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5‐fluorouracil

  1992cited by this paper
• Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.

  1992cited by this paper
• [Hypercalcemia in malignancy].

  1991cited by this paper
• Transplantation of human prostatic carcinoma into nude mice in Matrigel.

  1991cited by this paper
• A murine model of experimental metastasis to bone and bone marrow.

  1988cited by this paper
• Development of skeletal metastasis by human prostate cancer in athymic nude mice

  1988cited by this paper
• Prostate-specific antigen.

  1987cited by this paper
• Bone metastases in breast cancer, prostate cancer and myeloma.

  1987cited by this paper
• Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption.

  1987cited by this paper
• Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers

  1987cited by this paper
• Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones.

  1987cited by this paper
• Bone metastases in breast cancer, prostate cancer and myeloma.

  1987cited by this paper
• Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone.

  1986cited by this paper
• Generalised increase in bone resorption in carcinoma of the prostate.

  1985cited by this paper
• 0163-769X/98/$03.00/0 Endocrine Reviews 19(1): 18–54 Copyright © 1998 by The Endocrine Society Printed in U.S.A. Cancer and Bone*

  year unknowncited by this paper

• Longitudinal measurement of subcutaneous and intratibial human prostate cancer xenograft growth and response to ionizing radiation by plasma Alu and LINE‐1 ctDNA: A comparison to standard methods

  2021cites this paper
• Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells

  2019cites this paper
• Modelling human prostate cancer: Rat models

  2018cites this paper
• Human Bone Xenografts: from Preclinical Testing for Regenerative Medicine to Modeling of Diseases

  2016cites this paper
• Preclinical Cancer Pain Models

  2013cites this paper
• Macrophage cathepsin K promotes prostate tumor progression in bone

  2013cites this paper
• Xenograft, Transgenic, and Knockout Models of Prostate Cancer

  2013cites this paper
• A radiolabeled nonapeptide probe targeting PC-3 cells and bone metastases of prostate cancer in mice.

  2012cites this paper
• In Vitro Model of Metastasis to Bone Marrow Mediates Prostate Cancer Castration Resistant Growth through Paracrine and Extracellular Matrix Factors

  2012cites this paper
• Prostate Cancer Cells and Bone Stromal Cells Mutually Interact with Each Other through Bone Morphogenetic Protein-mediated Signals*

  2012cites this paper
• From Prostate to Bone: Key Players in Prostate Cancer Bone Metastasis

  2011cites this paper
• Immunodeficiency Provides Partial Protection from Bone Loss Induced by Castration and Ovariectomy

  2010cites this paper
• Animal models of cancer pain.

  2008cites this paper
• Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors

  2008cites this paper
• Gene targeting to the stroma of the prostate and bone.

  2008cites this paper
• Xenograft Models of Human Prostate Cancer

  2007cites this paper
• The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA.

  2006cites this paper
• Rat Models of Bone Metastases

  2006cites this paper
• Action of Calciotropic Hormones on Bone Metabolism-Role of Vitamin D3 in Bone Remodeling Events

  2006cites this paper
• Modèles animaux de perte osseuse bénigne et maligne utilisable pour l?évaluation de biomatériaux

  2006cites this paper
• Targeting of therapeutic agents to bone to treat metastatic cancer.

  2005cites this paper
• Spiculated periosteal response induced by intraosseous injection of 22Rv1 prostate cancer cells resembles subset of bone metastases in prostate cancer patients

  2005cites this paper
• Skeletal implications of prostate cancer.

  2003cites this paper
• Skeletal implications of prostate cancer.

  2003cites this paper